Abstract
In this paper, we study the commercialization dilemma of China's agriculture biotechnology from the the perspective of GM R&D capability. Firstly, we investigate government investment and the corresponding human capacity. Next, scientific papers&patents are analysised. Thirdly, we compare the R&D system between China and others and point out its disadvantages. Finally, we give some corresponding suggestions for healthy and sustainable development of China's agriculture biotechnology.
| Original language | English |
|---|---|
| Title of host publication | Proceedings of the 29th Chinese Control and Decision Conference, CCDC 2017 |
| Publisher | Institute of Electrical and Electronics Engineers Inc. |
| Pages | 1982-1985 |
| Number of pages | 4 |
| ISBN (Electronic) | 9781509046560 |
| DOIs | |
| Publication status | Published - 12 Jul 2017 |
| Event | 29th Chinese Control and Decision Conference, CCDC 2017 - Chongqing, China Duration: 28 May 2017 → 30 May 2017 |
Publication series
| Name | Proceedings of the 29th Chinese Control and Decision Conference, CCDC 2017 |
|---|
Conference
| Conference | 29th Chinese Control and Decision Conference, CCDC 2017 |
|---|---|
| Country/Territory | China |
| City | Chongqing |
| Period | 28/05/17 → 30/05/17 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Agriculture biotechnology
- GM
- R&D capability
- Sustainable agriculture
Fingerprint
Dive into the research topics of 'Study and suggestions on R&D competitiveness of China's GM crops'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver